English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Tools annual

Global: Zendy Free Plan

Global: Zendy Tools monthly

Global: Zendy Plus monthly

Humans have been fought with the lu all the time, and up till now. In recent years, the pandemic virus, including avian in luenza, infectious atypical pneumonia and the current novel coronavirus COVID-19, are life-threatening respiratory diseases. These diseases have become serious public health problems in worldwide, and in many developing countries, the problem is devastating. It is well known that the development in luenza vaccine is hysteretic generally, and some targeted drugs have been developed for treating in luenza, such as Oseltamivir, but the effect is lower cost-effectiveness and moved out of the recommended list by WHO [1]. It is necessary to ind effective drugs.

Pseudoephedrine protects mice from infection of H1N1 virus